In vitro susceptibility testing of filamentous fungi: Comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs

被引:38
作者
Pfaller, MA [1 ]
Messer, SA
Boyken, L
Hollis, RJ
Diekema, DJ
机构
[1] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Dept Med, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA
关键词
Etest; posaconazole; molds;
D O I
10.1016/S0732-8893(02)00544-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The performance of the Etest for posaconazole susceptibility testing of 72 isolates of filamentous fungi was assessed in comparison with the National Committee for Clinical Laboratory Standards (NCCLS) approved standard broth microdilution method (M38-A). The NCCLS method employed RPMI 1640 broth medium, and MICs were read after incubation for 48h at 35 degreesC. Etest MICs were determined with RPMI agar containing 2% glucose and were read after incubation for 48h at 35 degreesC. The isolates included Aspergillus fumigatus, A. flavus, A. nidulans, A. niger, A. versicolor, A. oryzae, A. terreus, Cladosporium spp., Curvularia sp., Exophiala sp., Fusarium spp., Paecilomyces spp., Pithomyces sp.. Penicillium spp. and Scedosporium apiospermum. Overall agreement between Etest and microdilution MICs was 84% for Aspergillus spp. and 100% for the less common opportunistic molds, with the exception of Penicillium spp. (67%). Where a discrepancy was observed between Etest and the reference method, the Etest tended to give lower values. The Etest method using RPMI agar appears to be a useful method for determining posaconazole susceptibilities of filamentous fungi. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:241 / 244
页数:4
相关论文
共 32 条
[1]   In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida [J].
Cacciapuoti, A ;
Loebenberg, D ;
Corcoran, E ;
Menzel, F ;
Moss, EL ;
Norris, C ;
Michalski, M ;
Raynor, K ;
Halpern, J ;
Mendrick, C ;
Arnold, B ;
Antonacci, B ;
Parmegiani, R ;
Yarosh-Tomaine, T ;
Miller, GH ;
Hare, RS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2017-2022
[2]   Burden of aspergillosis-related hospitalizations in the United States [J].
Dasbach, EJ ;
Davies, GM ;
Teutsch, SM .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) :1524-1528
[3]   Itraconazole resistance in Aspergillus fumigatus [J].
Denning, DW ;
Venkateswarlu, K ;
Oakley, KL ;
Anderson, MJ ;
Manning, NJ ;
Stevens, DA ;
Warnock, DW ;
Kelly, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1364-1368
[4]   An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome [J].
Denning, DW ;
Marinus, A ;
Cohen, J ;
Spence, D ;
Herbrecht, R ;
Pagano, L ;
Kibbler, C ;
Kcrmery, V ;
Offner, F ;
Cordonnier, C ;
Jehn, U ;
Ellis, M ;
Collette, L ;
Sylvester, R .
JOURNAL OF INFECTION, 1998, 37 (02) :173-180
[5]   E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents:: Comparison with NCCLS broth microdilution method [J].
Espinel-Ingroff, A ;
Rezusta, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2101-2107
[6]   Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.:: NCCLS collaborative evaluation [J].
Espinel-Ingroff, A ;
Bartlett, M ;
Chaturvedi, V ;
Ghannoum, M ;
Hazen, KC ;
Pfaller, MA ;
Rinaldi, M ;
Walsh, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1828-1835
[7]   Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1360-1367
[8]   Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956
[9]   Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi [J].
EspinelIngroff, A ;
Bartlett, M ;
Bowden, R ;
Chin, NX ;
Cooper, C ;
Fothergill, A ;
McGinnis, MR ;
Menezes, P ;
Messer, SA ;
Nelson, PW ;
Odds, FC ;
Pasarell, L ;
Peter, J ;
Pfaller, MA ;
Rex, JH ;
Rinaldi, MG ;
Shankland, GS ;
Walsh, TJ ;
Weitzman, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (01) :139-143
[10]   Uncommon opportunistic fungi: new nosocomial threats [J].
Groll, AH ;
Walsh, TJ .
CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 :8-24